期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
Potassium variability during hospitalization and outcomes after discharge in patients with acute myocardial infarction 被引量:2
1
作者 Xi-Ling ZHANG Heng-Xuan CAI +5 位作者 Shan-Jie WANG Xiao-Yuan ZHANG Xin-Ran HAO Shao-Hong FANG Xue-Qin GAO Bo YU 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2021年第1期10-19,共10页
BACKGROUND The variability of metabolic biomarkers has been determined to provide incremental prognosis information,but the implications of electrolyte variability remained unclear.METHODS We investigate the relations... BACKGROUND The variability of metabolic biomarkers has been determined to provide incremental prognosis information,but the implications of electrolyte variability remained unclear.METHODS We investigate the relationships between electrolyte fluctuation and outcomes in survivors of acute myocardial infarction(n=4386).Ion variability was calculated as the coefficient of variation,standard deviation,variability independent of the mean(VIM)and range.Hazard ratios(HR)were estimated using the multivariable-adjusted Cox proportional regression method.RESULTS During a median follow-up of 12 months,161(3.7%)patients died,and heart failure occurred in 550(12.5%)participants after discharge,respectively.Compared with the bottom quartile,the highest quartile potassium VIM was associated with increased risks of all-cause mortality(HR=2.35,95%CI:1.36–4.06)and heart failure(HR=1.32,95%CI:1.01–1.72)independent of cardiac troponin I(c Tn I),N terminal pro B type natriuretic peptide(NT-pro BNP),infarction site,mean potassium and other traditional factors,while those associations across sodium VIM quartiles were insignificant.Similar trend remains across the strata of variability by other three indices.These associations were consistent after excluding patients with any extreme electrolyte value and diuretic use.CONCLUSIONS Higher potassium variability but not sodium variability was associated with adverse outcomes post-infarction.Our findings highlight that potassium variability remains a robust risk factor for mortality regardless of clinical dysnatraemia and dyskalaemia. 展开更多
关键词 AMI BNP Potassium variability during hospitalization and outcomes after discharge in patients with acute myocardial infarction
下载PDF
Intravitreal triamcinolone acetonide: a "real world" analysis of visual acuity, pressure and outcomes 被引量:1
2
作者 Victor Manuel Villegas Aaron Samuel Gold +2 位作者 Andrea Wildner Azeema Latiff Timothy Garrett Murray 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2016年第5期789-791,共3页
Dear Sir,Triamcinolone acetonide(TA)is worldwide available therapeutic agent that is commonly used throughout medicine.TA remains a safe and important ophthalmic therapeutic agent even after the advent of angiogenes... Dear Sir,Triamcinolone acetonide(TA)is worldwide available therapeutic agent that is commonly used throughout medicine.TA remains a safe and important ophthalmic therapeutic agent even after the advent of angiogenesis inhibitors[1-2]. 展开更多
关键词 IOP TA analysis of visual acuity pressure and outcomes real world Intravitreal triamcinolone acetonide
下载PDF
Clinical manifestations and outcomes of ocular sarcoidosis in Saudi Arabia
3
作者 Samir S.Shoughy Mahmoud O.Jaroudi +1 位作者 Khalid F.Tabbara Igor Kozak 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2015年第6期1261-1263,共3页
Dear Sir,We write to report on the clinical manifestations and outcomes of ocular sarcoidosis in patients presenting to uveitis referral centers in the Kingdom of Saudi Arabia.This is the first report focused solely o... Dear Sir,We write to report on the clinical manifestations and outcomes of ocular sarcoidosis in patients presenting to uveitis referral centers in the Kingdom of Saudi Arabia.This is the first report focused solely on ocular sarcoidosis from this country. 展开更多
关键词 Clinical manifestations and outcomes of ocular sarcoidosis in Saudi Arabia CNV
下载PDF
Impact of payment source, referral site, and place of residence on outcomes after allogeneic transplantation in Mexico
4
作者 Andrés Gómez-De León Yesica A López-Mora +13 位作者 Valeria García-Zárate Ana Varela-Constantino Sergio U Villegas-De Leon Xitlaly J González-Leal Raúl del Toro-Mijares Anna C Rodríguez-Zúñiga Juan F Barrios-Ruiz Victor Mingura-Ledezma Perla R Colunga-Pedraza Olga G Cantú-Rodríguez César H Gutiérrez-Aguirre Luz Tarín-Arzaga Elías E González-López David Gómez-Almaguer 《World Journal of Transplantation》 2024年第2期76-87,共12页
BACKGROUND The impact of social determinants of health in allogeneic transplant recipients in low-and middle-income countries is poorly described.This observational study analyzes the impact of place of residence,refe... BACKGROUND The impact of social determinants of health in allogeneic transplant recipients in low-and middle-income countries is poorly described.This observational study analyzes the impact of place of residence,referring institution,and transplant cost coverage(out-of-pocket vs government-funded vs private insurance)on outcomes after allogeneic hematopoietic stem cell transplantation(alloHSCT)in two of Mexico's largest public and private institutions.AIM To evaluate the impact of social determinants of health and their relationship with outcomes among allogeneic transplant recipients in Mexico.METHODS In this retrospective cohort study,we included adolescents and adults≥16 years who received a matched sibling or haploidentical transplant from 2015-2022.Participants were selected without regard to their diagnosis and were sourced from both a private clinic and a public University Hospital in Mexico.Three payment groups were compared:Out-of-pocket(OOP),private insurance,and a federal Universal healthcare program“Seguro Popular”.Outcomes were compared between referred and institution-diagnosed patients,and between residents of Nuevo Leon and out-of-state.Primary outcomes included overall survival(OS),categorized by residence,referral,and payment source.Secondary outcomes encompassed early mortality,event-free-survival,graft-versus-host-relapse-free survival,and non-relapse-mortality(NRM).Statistical analyses employed appropriate tests,Kaplan-Meier method,and Cox proportional hazard regression modeling.Statistical software included SPSS and R with tidycmprsk library.RESULTS Our primary outcome was overall survival.We included 287 patients,n=164 who lived out of state(57.1%),and n=129 referred from another institution(44.9%).The most frequent payment source was OOP(n=139,48.4%),followed by private insurance(n=75,26.1%)and universal coverage(n=73,25.4%).No differences in OS,event-free-survival,NRM,or graft-versus-host-relapse-free survival were observed for patients diagnosed locally vs in another institution,nor patients who lived in-state vs out-of-state.Patients who covered transplant costs through private insurance had the best outcomes with improved OS(median not reached)and 2-year cumulative incidence of NRM of 14%than patients who covered costs OOP(Median OS and 2-year NRM of 32%)or through a universal healthcare program active during the study period(OS and 2-year NRM of 19%)(P=0.024 and P=0.002,respectively).In a multivariate analysis,payment source and disease risk index were the only factors associated with overall survival.CONCLUSION In this Latin-American multicenter study,the site of residence or referral for alloHSCT did not impact outcomes.However,access to healthcare coverage for alloHSCT was associated with improved OS and reduced NRM. 展开更多
关键词 Hematopoietic cell transplant Social determinants of health Geography HAPLOIDENTICAL OUT-OF-POCKET Financial toxicity Survival Health services and outcomes Hematopoietic malignancy Aplastic anemia
下载PDF
Predictors and outcomes of photodynamic therapy on circumscribed choroidal hemangiomas in Chinese patients
5
作者 Wang Mingyang Zhang Xinyuan +1 位作者 Wang Yanhong Wang Guanglu 《Chinese Medical Journal》 SCIE CAS CSCD 2014年第15期2874-2876,共3页
Choroidal hemangiomas (CHs) are relatively rare,benign,vascular,hamartomatous tumors.They are categorized to circumscribed choroidal hemangiomas (CCHs) or diffuse choroidal hemangiomas (DCHs) clinically and hist... Choroidal hemangiomas (CHs) are relatively rare,benign,vascular,hamartomatous tumors.They are categorized to circumscribed choroidal hemangiomas (CCHs) or diffuse choroidal hemangiomas (DCHs) clinically and histologically.Although circumscribed CHs (CCHs) are often asymptomatic,they can affect visual acuity (VA) if they are situated beneath the fovea,where they can cause accumulation of secondary subretinal fluid and/or cystic retinal degeneration.Due to its minimal invasiveness and negligible toxicity to the normal retina,photodynamic therapy (PDT) with verteporfin has been applied widely in the treatment of CCH.1 Treatment strategies for CCHs should take into account tumor size,anatomic location,VA,and presence/absence of complications.The present study was conducted to identify potential predictors of successful PDT treatment other than those previously reported.We also present alternative treatment modalities for larger,more complicated CCHs.Keywords:circumscribed choroidalhemangiomas; photodynamic therapy; tumor height; predictors and outcomes;success rate;fluorescence angiography; indocyanine green angiography 展开更多
关键词 circumscribed choroidalhemangiomas photodynamic therapy tumor height predictors and outcomes success rate fluorescence angiography indocyanine green angiography
原文传递
Doing the right things and doing them the right way: association between hospital guideline adherence, dosing safety, and outcomes among patients with acute coronary syndrome
6
《South China Journal of Cardiology》 CAS 2015年第1期62-62,共1页
Background Performance metrics currently focus on the measurement of the application of guideline-indi- cated medications without considering the appropriate dosing of these drugs.
关键词 AHA dosing safety Doing the right things and doing them the right way and outcomes among patients with acute coronary syndrome association between hospital guideline adherence
原文传递
Audit of Neonatal Jaundice as Experienced at a Mission Hospital in Western Nigeria
7
作者 Joel-Medewase Victor Idowu 《Open Journal of Pediatrics》 2024年第1期50-62,共13页
Introduction: Neonatal jaundice (NNJ) is a common disorder in neonates that can impact negatively on the brain and cause death. The peculiarities in aetiology and solutions for different settings are a knowledge gap. ... Introduction: Neonatal jaundice (NNJ) is a common disorder in neonates that can impact negatively on the brain and cause death. The peculiarities in aetiology and solutions for different settings are a knowledge gap. This informed the desire to determine local aetiology and solutions for neonatal jaundice in a missionary hospital in Abeokuta, Southwestern Nigeria. Methods: Consecutive consenting babies diagnosed with significant neonatal jaundice were studied between July 2016 and June 2019. Institutional ethical consent was obtained. A proforma was used to obtain socio-demographic data and other relevant information such as age, sex, birthweight, gestational age and history regarding the jaundice. All the information obtained was inputted into a computer and analysed with SPSS version 16. Results: A total of 179 babies with neonatal jaundice comprising of 120 (67.0%) boys and 59 (33.0%) girls with ages ranging between 1 and 12 days (mean 2.7 ± 2.9) were studied. Prematurity, ABO incompatibility, neonatal sepsis and glucose-6-phosphate enzyme deficiency accounted for over 80% of the causes of significant NNJ. Sixty (33.5%) of the 179 babies studied developed acute bilirubin encephalopathy and 11 (6.1%) mortalities were recorded. Higher proportions of babies that were out-born with spontaneous vaginal delivery modes had acute bilirubin encephalopathy (p < 0.05). Mothers with formal education had better outcome compared to mothers without, in terms of mortalities (p < 0.05). Conclusion: Neonatal jaundice is still a significant cause of morbidity and mortality in the neonatal age group. Maternal education is key to good outcome in neonatal jaundice. 展开更多
关键词 JAUNDICE NEONATES Bilirubinaemia Encephalopathy and outcomes
下载PDF
Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots 被引量:1
8
作者 Per-Anders Abrahamsson 《Asian Journal of Urology》 2017年第4期208-222,共15页
Intermittent androgen deprivation therapy(IADT)is now being increasingly opted by the treating physicians and patients with prostate cancer.The most common reason driving this is the availability of an off-treatment p... Intermittent androgen deprivation therapy(IADT)is now being increasingly opted by the treating physicians and patients with prostate cancer.The most common reason driving this is the availability of an off-treatment period to the patients that provides some relief from treatment-related side-effects,and reduced treatment costs.IADT may also delay the progression to castration-resistant prostate cancer.However,the use of IADT in the setting of prostate cancer has not been strongly substantiated by data from clinical trials.Multiple factors seem to contribute towards this inadequacy of supportive data for the use of IADT in patients with prostate cancer,e.g.,population characteristics(both demographic and clinical),study design,treatment regimen,on-and off-treatment criteria,duration of active treatment,endpoints,and analysis.The present review article focuses on seven clinical trials that evaluated the efficacy of IADT vs.continuous androgen deprivation therapy for the treatment of prostate cancer.The results from these clinical trials have been discussed in light of the factors that may impact the treatment outcomes,especially the disease(tumor)burden.Based on evidence,potential candidate population for IADT has been suggested along with recommendations for the use of IADT in patients with prostate cancer. 展开更多
关键词 Continuous androgen deprivation therapy Intermittent androgen deprivation therapy Prostate cancer Study designs and outcomes Tumor burden
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部